Immunome, Inc. (IMNM)
18.31
-0.45
(-2.40%)
USD |
NASDAQ |
Oct 29, 16:00
18.31
0.00 (0.00%)
After-Hours: 19:33
Immunome Market Cap : 2.076B for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 2.127B |
| October 27, 2026 | 2.129B |
| October 26, 2026 | 2.029B |
| October 23, 2026 | 2.040B |
| October 22, 2026 | 2.071B |
| October 21, 2026 | 2.041B |
| October 20, 2026 | 2.032B |
| October 19, 2026 | 1.902B |
| October 16, 2026 | 1.868B |
| October 15, 2026 | 1.973B |
| October 14, 2026 | 1.950B |
| October 13, 2026 | 1.994B |
| October 12, 2026 | 2.172B |
| October 09, 2026 | 2.217B |
| October 08, 2026 | 2.190B |
| October 07, 2026 | 2.165B |
| October 06, 2026 | 2.190B |
| October 05, 2026 | 2.401B |
| October 02, 2026 | 2.370B |
| October 01, 2026 | 2.369B |
| September 30, 2026 | 2.439B |
| September 29, 2026 | 2.482B |
| September 28, 2026 | 2.458B |
| September 25, 2026 | 2.428B |
| September 24, 2026 | 2.533B |
| Date | Value |
|---|---|
| September 23, 2026 | 2.749B |
| September 22, 2026 | 2.920B |
| September 21, 2026 | 2.843B |
| September 18, 2026 | 2.718B |
| September 17, 2026 | 2.714B |
| September 16, 2026 | 2.660B |
| September 15, 2026 | 2.716B |
| September 14, 2026 | 2.784B |
| September 11, 2026 | 2.798B |
| September 10, 2026 | 2.832B |
| September 09, 2026 | 2.962B |
| September 08, 2026 | 3.040B |
| September 04, 2026 | 3.035B |
| September 03, 2026 | 3.080B |
| September 02, 2026 | 3.099B |
| September 01, 2026 | 3.069B |
| August 31, 2026 | 3.108B |
| August 28, 2026 | 3.126B |
| August 27, 2026 | 3.274B |
| August 26, 2026 | 3.260B |
| August 25, 2026 | 3.332B |
| August 24, 2026 | 3.176B |
| August 21, 2026 | 3.234B |
| August 20, 2026 | 3.184B |
| August 19, 2026 | 3.382B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.537B |
| Revolution Medicines, Inc. | 40.78B |
| Erasca, Inc. | 4.688B |
| Oncolytics Biotech, Inc. | 53.26M |
| Sangamo Therapeutics, Inc. | 48.88M |
Market Cap Related Metrics
| Price to Book Value | 3.954 |
| Price | 18.31 |
| Earnings Yield | -13.80% |